Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Providing reliable access to innovative medicines in the areas of haematology, immunology and specialty care, Sobi has approximately 2,000 employees across Europe, North America, the Middle East, Asia, and Australia.
In 2025, revenue amounted to SEK 28 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm.
Jefferies Global Healthcare Conference, London
Sobi presents on Tuesday 17 November at 13:00 CET / 12:00 GMT. Follow the presentation live via the link below.
Q3 2026 report
Sobi has published its Q3 2026 report on 27 October 2026.
Sobi Capital Markets Day 2026
Sobi hosted a Capital Markets Day on 18 February 2026.